Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

ClinicalTrials.gov ID: NCT06285643

Public ClinicalTrials.gov record NCT06285643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults With Moderate Stage Parkinson's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.

Study identification

NCT ID
NCT06285643
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AskBio Inc
Industry
Enrollment
127 participants

Conditions and interventions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
45 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2024 (Actual)
Primary completion
Aug 31, 2028 (Estimated)
Completion
Aug 31, 2028 (Estimated)
Last update posted
Oct 1, 2026

2024 – 2028

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
29
Facility City State ZIP Site status
Mayo Clinic Phoenix Arizona 85054 —
UCI Alpha Clinic (Neurology) Irvine California 92697 —
Loma Linda University (Neurology) Loma Linda California 92354 —
Loma Linda University (Surgical) Loma Linda California 92354 —
University of California San Francisco (Neurology) San Francisco California 94143 —
University of San Francisco (Surgical) San Francisco California 94143 —
CenExel Rocky Mountain Clinical Research (Neurology) Englewood Colorado 80113 —
Georgetown University (Neurology) Washington D.C. District of Columbia 20057 —
Parkinson's Disease and Movement Disorders Center of Boca Raton (Neurology) Boca Raton Florida 33486 —
University of Florida Gainesville Florida 32608 —
University of Miami Miami Florida 33125 —
Orlando Health Neuroscience Institute Orlando Florida 32806 —
Parkinson's Disease Treatment Center of Southwest Florida (Neurology) Port Charlotte Florida 33980 —
Emory University (Surgical) Atlanta Georgia 30322 —
Rush University Medical Center (Neurology) Chicago Illinois 60612 —
University of Kansas Medical Center (Neurology) Kansas City Kansas 66103 —
Massachusetts General Hospital (Neurology) Boston Massachusetts 02114 —
Massachusetts General Hospital (Surgical) Boston Massachusetts 02114 —
Michigan State University (Neurology) East Lansing Michigan 48824 —
Quest Research Institute (Neurology) Farmington Hills Michigan 48334 —
Cleveland Clinic Lou Ruvo (Neurology) Las Vegas Nevada 89106 —
Columbia University New York New York 10032 —
University of North Carolina (Neurology) Chapel Hill North Carolina 27514 —
Duke Neurosurgery (Surgical) Durham North Carolina 27705 —
Duke University (Neurology) Durham North Carolina 27710 —
Ohio State University (Surgical) Columbus Ohio 43210 —
University of Pennsylvania (Neurology) Philadelphia Pennsylvania 19104 —
Vanderbilt University (Neurology) Nashville Tennessee 37232 —
Texas Movement Disorder Specialists Georgetown Texas 78628 —
Houston Methodist (Neurology) Houston Texas 77030 —
Houston Methodist (Surgical) Houston Texas 77030 —
University of Utah Salt Lake City Utah 84132 —
EvergreenHealth Research Department (Neurology) Kirkland Washington 98034 —
University of Wisconsin (Neurology) Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06285643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06285643 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →